Hirotaka Kushida

1.0k total citations
32 papers, 860 citations indexed

About

Hirotaka Kushida is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Hirotaka Kushida has authored 32 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 15 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Hirotaka Kushida's work include Pharmacogenetics and Drug Metabolism (10 papers), Alkaloids: synthesis and pharmacology (9 papers) and Pharmacological Effects of Natural Compounds (9 papers). Hirotaka Kushida is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Alkaloids: synthesis and pharmacology (9 papers) and Pharmacological Effects of Natural Compounds (9 papers). Hirotaka Kushida collaborates with scholars based in Japan, United Kingdom and United States. Hirotaka Kushida's co-authors include Akihiro Suzuki, Tetsuya Kamataki, Ken‐ichi Fujita, Yasushi Ikarashi, Yoshio Kase, Takashi Matsumoto, Takehiko Nohmi, Hiroshi Iwata, Katsunori Nakamura and Masami Yamada and has published in prestigious journals such as Scientific Reports, Molecules and Biochemical Pharmacology.

In The Last Decade

Hirotaka Kushida

32 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hirotaka Kushida Japan 16 527 339 137 111 90 32 860
Mitsuaki Kitano Japan 20 333 0.6× 637 1.9× 63 0.5× 68 0.6× 117 1.3× 43 1.2k
Kaustubh H. Kulkarni United States 12 204 0.4× 346 1.0× 137 1.0× 134 1.2× 32 0.4× 18 945
Meijuan Xu China 17 290 0.6× 509 1.5× 86 0.6× 110 1.0× 38 0.4× 52 944
Phillip J. Daschner United States 8 173 0.3× 426 1.3× 125 0.9× 62 0.6× 144 1.6× 11 875
Aleksanteri Petsalo Finland 17 262 0.5× 299 0.9× 164 1.2× 58 0.5× 17 0.2× 24 682
Orhan Adalı Türkiye 16 176 0.3× 238 0.7× 78 0.6× 68 0.6× 47 0.5× 42 654
Defeng Li China 17 212 0.4× 466 1.4× 72 0.5× 108 1.0× 43 0.5× 45 872
Nak Doo Kim South Korea 13 466 0.9× 819 2.4× 37 0.3× 111 1.0× 48 0.5× 27 1.1k
Hai Wei China 18 224 0.4× 438 1.3× 87 0.6× 92 0.8× 39 0.4× 39 1.0k
Guixiang Pan China 15 287 0.5× 439 1.3× 42 0.3× 144 1.3× 27 0.3× 50 974

Countries citing papers authored by Hirotaka Kushida

Since Specialization
Citations

This map shows the geographic impact of Hirotaka Kushida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirotaka Kushida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirotaka Kushida more than expected).

Fields of papers citing papers by Hirotaka Kushida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirotaka Kushida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirotaka Kushida. The network helps show where Hirotaka Kushida may publish in the future.

Co-authorship network of co-authors of Hirotaka Kushida

This figure shows the co-authorship network connecting the top 25 collaborators of Hirotaka Kushida. A scholar is included among the top collaborators of Hirotaka Kushida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirotaka Kushida. Hirotaka Kushida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishi, Akinori, Katsuya Ohbuchi, Hirotaka Kushida, et al.. (2021). Publisher Correction: LimeMap: a comprehensive map of lipid mediator metabolic pathways. npj Systems Biology and Applications. 7(1). 16–16. 1 indexed citations
2.
Kushida, Hirotaka, Takashi Matsumoto, & Yasushi Ikarashi. (2021). Properties, Pharmacology, and Pharmacokinetics of Active Indole and Oxindole Alkaloids in Uncaria Hook. Frontiers in Pharmacology. 12. 688670–688670. 38 indexed citations
3.
Kushida, Hirotaka, Takashi Matsumoto, Yasushi Ikarashi, Hiroaki Nishimura, & Masahiro Yamamoto. (2020). Gender differences in plasma pharmacokinetics and hepatic metabolism of geissoschizine methyl ether from Uncaria hook in rats. Journal of Ethnopharmacology. 264. 113354–113354. 9 indexed citations
4.
Kitagawa, Hiroyuki, Katsuya Ohbuchi, Masaya Munekage, et al.. (2018). Phenotyping analysis of the Japanese Kampo medicine maoto in healthy human subjects using wide-targeted plasma metabolomics. Journal of Pharmaceutical and Biomedical Analysis. 164. 119–127. 13 indexed citations
5.
Kitagawa, Hiroyuki, Katsuya Ohbuchi, Masaya Munekage, et al.. (2018). Data on metabolic profiling of healthy human subjects’ plasma before and after administration of the Japanese Kampo medicine maoto. Data in Brief. 22. 359–364. 9 indexed citations
6.
Matsumoto, Takashi, Hirotaka Kushida, Shoko Matsushita, et al.. (2017). Distribution Analysis via Mass Spectrometry Imaging of Ephedrine in the Lungs of Rats Orally Administered the Japanese Kampo Medicine Maoto. Scientific Reports. 7(1). 44098–44098. 15 indexed citations
7.
Nishi, Akinori, Katsuya Ohbuchi, Hirotaka Kushida, et al.. (2017). Deconstructing the traditional Japanese medicine “Kampo”: compounds, metabolites and pharmacological profile of maoto, a remedy for flu-like symptoms. npj Systems Biology and Applications. 3(1). 32–32. 26 indexed citations
8.
Kushida, Hirotaka, et al.. (2016). Ginsenosides, ingredients of the root of Panax ginseng, are not substrates but inhibitors of sodium-glucose transporter 1. Journal of Natural Medicines. 71(1). 131–138. 13 indexed citations
9.
Omiya, Yuji, et al.. (2015). Effects of shakuyakukanzoto and its absorbed components on twitch contractions induced by physiological Ca2+ release in rat skeletal muscle. Journal of Natural Medicines. 69(3). 287–295. 20 indexed citations
10.
Matsumoto, Takashi, Hirotaka Kushida, Takeshi Maruyama, et al.. (2015). In vitroidentification of human cytochrome P450 isoforms involved in the metabolism of Geissoschizine methyl ether, an active component of the traditional Japanese medicine Yokukansan. Xenobiotica. 46(4). 325–334. 6 indexed citations
11.
Watanabe, Junko, Hirotaka Kushida, Takashi Matsumoto, et al.. (2015). Intestinal, portal, and peripheral profiles of daikenchuto (TU‐100)'s active ingredients after oral administration. Pharmacology Research & Perspectives. 3(5). e00165–e00165. 16 indexed citations
12.
Mizoguchi, Kazushige, Hirotaka Kushida, Hitomi Kanno, et al.. (2014). Specific binding and characteristics of geissoschizine methyl ether, an indole alkaloid of Uncaria Hook, in the rat brain. Journal of Ethnopharmacology. 158. 264–270. 13 indexed citations
14.
Asano, Takayuki, Hirotaka Kushida, Chiharu Sadakane, et al.. (2001). Metabolism of Ipecac Alkaloids Cephaeline and Emetine by Human Hepatic Microsomal Cytochrome P450s, and Their Inhibitory Effects on P450 Enzyme Activities.. Biological and Pharmaceutical Bulletin. 24(6). 678–682. 18 indexed citations
15.
Kushida, Hirotaka, Ken‐ichi Fujita, Akihiro Suzuki, et al.. (2000). Metabolic activation of N -alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. Carcinogenesis. 21(6). 1227–1232. 78 indexed citations
16.
Kushida, Hirotaka, Ken‐ichi Fujita, Akihiro Suzuki, et al.. (2000). Development of a Salmonella tester strain sensitive to promutagenic N-nitrosamines: expression of recombinant CYP2A6 and human NADPH-cytochrome P450 reductase in S. typhimurium YG7108. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 471(1-2). 135–143. 28 indexed citations
17.
Kushida, Hirotaka, Ken‐ichi Fujita, Akihiro Suzuki, et al.. (2000). Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. Carcinogenesis. 21(6). 1227–1232. 23 indexed citations
18.
Ikarashi, Yasushi, et al.. (2000). Effects of subacutely administered saiboku-to, an oriental herbal medicine, on pharmacodynamics and pharmacokinetics of diazepam in rodents. European Journal of Drug Metabolism and Pharmacokinetics. 25(2). 127–136. 6 indexed citations
19.
Kamataki, Tetsuya, et al.. (1999). Genetic polymorphism of CYP2A6 in relation to cancer. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 428(1-2). 125–130. 63 indexed citations
20.
Suzuki, Akihiro, Hirotaka Kushida, Hiroshi Iwata, et al.. (1999). Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocyclic amines. Cancer Letters. 143(2). 113–116. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026